ICU
SeaStar Medical Holding Corporation
There isn't enough reported data to score ICU yet.
ICU Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
ICU's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ICU PE Valuation
ICU has no meaningful PE right now: it lost money over the past year.
ICU Forward outlook
There aren't enough analyst estimates for ICU to show an outlook.
ICU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$191.94 | +$818.06 |
| Q2 2024 | -$273.44 | +$656.56 |
ICU is still losing money, but far less than before: $191.94 per share over the past year, against $1,010.00 at its worst in late 2023.
ICU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $635K | +247% |
| Q2 2026 | $615K | +82% |
| Q1 2026 | $495K | +69% |
| Q4 2025 | $420K | +527% |
| Q3 2025 | $183K | +169% |
ICU's revenue has grown year over year every quarter since mid-2025: $635,000 last quarter, up 247% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -721% | +1234 points |
| Q2 2026 | -616% | -97 points |
| Q1 2026 | -728% | +577 points |
| Q4 2025 | -718% | +6397 points |
| Q3 2025 | -1956% | +4597 points |
| Q2 2025 | -520% | N/A |
| Q1 2025 | -1304% | N/A |
| Q4 2024 | -7115% | N/A |
ICU's operating margin was −721% last quarter, up 1234 points from the same quarter a year ago.
ICU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.4M | +$471K |
| Q2 2026 | -$3M | +$13K |
| Q1 2026 | -$2.8M | -$107K |
| Q4 2025 | -$4.1M | +$599K |
| Q3 2025 | -$3.8M | +$1.2M |
| Q2 2025 | -$3M | -$183K |
| Q1 2025 | -$2.7M | +$834K |
| Q4 2024 | -$4.7M | -$208K |
ICU has burned cash in almost every quarter: −$13M over the past year, against −$14M the year before.
ICU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.5% | +306K shares |
| 1 year | +288% | +3.3M shares |
| 3 years | +8327% | +4.3M shares |
ICU has 4M diluted shares, up 288% from a year ago.
ICU Net Leverage
ICU's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ICU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 1.8 | Oversold |
ICU's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
ICU PE vs Healthcare Sector
ICU has no meaningful PE right now: it lost money over the past year.
ICU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.77 | 62% below |
| 20 week MA | $3.27 | 68% below |
| 50 week MA | $3.17 | 67% below |
| 100 week MA | $7.35 | 86% below |
| 200 week MA | $104.7 | 99% below |
ICU is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
ICU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $2,452.5 | $2,497.5 | +1.8% |
| 2022 | $2,497.5 | $995.0 | -60% |
| 2023 | $995.0 | $110.7 | -89% |
| 2024 | $110.7 | $20.4 | -82% |
| 2025 | $20.4 | $2.56 | -87% |
| 2026 YTD | $2.56 | $1.05 | -59% |
ICU has finished four years in a row lower, and it's down 59% so far in 2026.